The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related ...

It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

Since then, Wobble Genomics, Kuo’s spin-off from the University of Edinburgh, UK, has grown from 2 to 16 employees, and in ...

PanGIA Biotech, a leader in true liquid biopsy technology, is pleased to announce the appointment of Curtiss McNair as Vice ...

A homegrown biotech focused on infectious diseases like Ebola and Zika virus has shuttered a major component of its business.

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

South San Francisco biotech Pionyr was sold two years ago. Now three of its leaders want to test a trio of drugs beyond ...

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...